Showing results (61-70 of 331) with videos related to

Sort By:
Pageof 34
Journal of Cancer Research and Clinical Oncology|August 17, 2022
Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistanceJung Sun Kim, Soyeon Kim, Jaemoon Koh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 31, 2012
Surrogate decision-making in Korean patients with advanced cancer: a longitudinal studyJune Koo Lee, Bhumsuk Keam, Ah Reum An, et al.
Journal of Cancer Research and Clinical Oncology|July 10, 2014
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancerSung Hoon Sim, Bhumsuk Keam, Dong-Wan Kim, et al.
Cancer Research and Treatment|December 30, 2014
The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung CancerJune-Koo Lee, Dong-Wan Kim, Bhumsuk Keam, et al.
Insights Into Imaging|October 25, 2023
Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitorsJi Eun Park, Jaemin Jo, Jeonghwan Youk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion MutationsYusoo Lee, Tae Min Kim, Dong-Wan Kim, et al.
Cancer Research and Treatment|May 23, 2023
Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerMiso Kim, Soyeon Kim, Jeemin Yim, et al.
Molecular Cancer Therapeutics|February 18, 2016
Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung CancerJi-Young Jang, Yong-Goo Kim, Soo Jeong Nam, et al.
Cancer Research and Treatment|October 13, 2018
Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor CapmatinibSeulki Kim, Tae Min Kim, Dong-Wan Kim, et al.
Journal of Korean Medical Science|June 20, 2023
Ethical Issues Referred to Clinical Ethics Support at a University Hospital in Korea: Three-Year Experience After Enforcement of Life-Sustaining Treatment Decisions ActShin Hye Yoo, Yejin Kim, Wonho Choi, et al.
Pageof 34